Practice
Featured experience
FTC clearance of Novo Nordisk acquisition of certain Catalent sites
We secured regulatory approval following a lengthy review
Syngenta antitrust litigation victory
We secured the dismissal of a price-fixing antitrust suit
Favorable plea deal for paving company in bid-rigging case
We represented the defendant in a DOJ antitrust investigation, securing a favorable plea deal
Antitrust advice to AI company
We are advising our client on a range of antitrust issues
Ferrero Group acquisition of Power Crunch
We are advising Ferrero on the transaction
ASMedia Technology $390 million acquisition of Techpoint
We are advising ASMedia on the transaction
Rokt $300 million merger with mParticle
We are advising Rokt on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
Teoxane proposal to acquire Revance Therapeutics
We are advising Teoxane on the proposed acquisition
Paychex $4.1 billion acquisition of Paycor HCM
We are advising Paychex on the transaction
Prosus $1.7 billion acquisition of Despegar.com
We are advising Prosus on the acquisition
FTC clearance of Novo Nordisk acquisition of certain Catalent sites
We secured regulatory approval following a lengthy review